Form 483

International Laboratories Corp., Limited Form 483, 2024-09-20

FDA issued a Form 483 to International Laboratories Corp., Limited on 2024-09-20 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

International Laboratories Corp., Limited · Bang Phli, Thailand · Issued September 20, 2024

Overview

  • 7 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Sep 2024
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Tamil Arasu, Samantha E Cleek

20 Sep 2024
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Tamil Arasu, Samantha E Cleek

20 Sep 2024
21 CFR 211.160(b)(1)

Samples (various types) representative, identified properly

Cited by Tamil Arasu, Samantha E Cleek

20 Sep 2024
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Tamil Arasu, Samantha E Cleek

20 Sep 2024
21 CFR 211.194(a)

Complete test data included in records

Cited by Tamil Arasu, Samantha E Cleek

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 7 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere